title: Response to letter regarding article, "rosiglitazone and outcomes for patients with diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial".
authors.affiliation: Cardiovascular Division, Department of Medicine, Washington University School of Medicine, Saint Louis, MO.
authors.forename: Richard G
authors.initials: RG
authors.lastname: Bach
authors.forename: Maria Mori
authors.initials: MM
authors.lastname: Brooks
authors.forename: Manuel
authors.initials: M
authors.lastname: Lombardero
authors.forename: Saul
authors.initials: S
authors.lastname: Genuth
authors.forename: Thomas W
authors.initials: TW
authors.lastname: Donner
authors.forename: Alan
authors.initials: A
authors.lastname: Garber
authors.forename: Laurence
authors.initials: L
authors.lastname: Kennedy
authors.forename: E Scott
authors.initials: ES
authors.lastname: Monrad
authors.forename: Rodica
authors.initials: R
authors.lastname: Pop-Busui
authors.forename: Sheryl F
authors.initials: SF
authors.lastname: Kelsey
authors.forename: Robert L
authors.initials: RL
authors.lastname: Frye
mesh_terms: D017130:Angioplasty; D002986:Clinical Trials as Topic / Q000592:standards; D001026:Coronary Artery Bypass; D003324:Coronary Artery Disease / Q000188:drug therapy* / Q000453:epidemiology / Q000601:surgery; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000453:epidemiology / Q000601:surgery; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000139:chemically induced; D000077154:Rosiglitazone; D045162:Thiazolidinediones / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D000077154:Rosiglitazone